Resources

Past Presentation

Nonalcoholic Fatty Liver Disease (NAFLD) and Diabetes | June 10, 2021

Date of Presentation: June 10, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Diabetes ECHO Program  

Keywords: #NAFLD  #NASH  #nonalcoholic fatty liver disease  #nonalcoholic steatohepatitis  

Dr. Mary Carol Greenlee, practitioner at Western Slope Endocrinology in Grand Junction, Colorado, discusses the etiology and disease progression of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic steatohepatitis (NASH) in patients with diabetes. Dr. Greenlee outlines common adverse outcomes, recognizing risk factors for this largely asymptomatic disease, pros and cons of screening and diagnostic tools, and strategies that can improve and, in many cases, reverse NAFLD and NASH in patients with diabetes who have not reached cirrhosis.

 

 

Recording:

Presenter Bio:

Dr. Mary Carol Greenlee

Mary Carol Greenlee, MD, FACP, FACE, is board certified in Internal Medicine and Endocrinology, Diabetes and Metabolism and is in private practice at Western Slope Endocrinology in Grand Junction, Colorado. She is currently serving on the Endocrine Society Council after several years on the Society’s Clinical Affairs Core Committee. She has a special interest in care delivery issues and has been actively involved with the collaborative project sponsored by the Endocrine Society to develop tools to assist with transition from pediatric to adult care for patients with endocrine disorders.

Resource Provided:

Date added: June 10, 2021